Loading...
Mountain Valley MD Holdings Inc.
MVMD.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.02
CA$-0.01(-20.00%)

Over the past four quarters, Mountain Valley MD Holdings Inc. demonstrated steady revenue growth, increasing from $60000.00 in Q3 2023 to $0.00 in Q2 2024. Operating income reached $0.00 in Q2 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$540000.00, reflecting operational efficiency. Net income rose to -$568000.00, with EPS at -$0.002. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan